Esperion Therapeutics Stock News

Esperion Therapeutics (ESPR) reported earnings 30 days ago. What's next for the stock?

ANN ARBOR, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that President and Chief Executive Officer, Sheldon Koenig, will participate in a fireside chat at the upcom

Esperion Therapeutics reported their Q1 earnings that revealed a beat on EPS and revenue. The company reported $13.4M in U.S. product revenue for Q1, which was up around 109% year-over-year.

Esperion Therapeutics (ESPR) reports solid first-quarter results, beating estimates for earnings and sales. Cost-savings programs boost margins.

Esperion Therapeutics, Inc. (NASDAQ:ESPR ) Q1 2022 Earnings Conference Call May 3, 2022 8:00 AM ET Company Participants Tiffany Aldrich - Senior Manager, Corporate Communications Sheldon Koenig - Pres

Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of 3.12% and 21.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Let's look at the five biotech/pharma companies, slated to release quarterly results on May 3.

ANN ARBOR, Mich., April 19, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced it will report first quarter 2022 financial results before the open of the U.S. financial markets on Tuesd

Esperion's (ESPR) stock rallies so far this year on higher product sales in the fourth quarter of 2021. Cost-saving initiatives to boost margins in 2022 are another key drivers.

The commercial-stage pharma company, Esperion Therapeutics (ESPR) announced on Tuesday that the company’s Chief Financial Officer Richard B

Gainers: Incannex Healthcare Limited IXHL +271%. Esperion Therapeutics (ESPR) +10%

H.C. Wainwright has started the coverage on Esperion Therapeutics <> with a Buy recommendation on Thursday, citing the commercial-stage pharma company’s lead products…

Esperion Therapeutics recently reported their Q4 and full-year 2021 earnings. NEXLETOL and NEXLIZET together secured $12.2M in U.S. net product revenue, which is up 200% for the year.

Gainers Imperial Petroleum Inc. (NASDAQ: IMPP ) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday. Indonesia Energy Corporation Limited (NYSE: INDO ) shares surged 44.1% to close at $6.47 on Tuesday. Meritor, Inc. (NYSE: MTOR ) shares climbed 43.8% to settle at $35.47. Cummins Inc (NYSE: CMI ) agreed to acquire electric powertrain solutions provider Meritor for about $3.7 billion, including assumed debt and net of acquired cash. China Natural Resources, Inc. (NASDAQ: CHNR ) surged 27.4% to close at $0.7901. Paltalk, Inc. (NASDAQ: PALT ) rose 26.1% to close at $3.96. Ocugen, Inc. (NASDAQ: OCGN ) gained 22.3% to close at $4.23. The FDA has lifted its clinical hold on Ocugens investigational new drug application seeking approval to conduct testing of the COVID-19 vaccine Covaxin in the U.S. Arteris, Inc. (NASDAQ: AIP ) climbed 19% to close at $17.83. Arteris is expected release its financial results for the fourth quarter on Thursday, March 3, 2022. SeaChange International, Inc. (NYSE: SEAC ) rose 18.9% to settle at $1.26.